![](https://www.diabetesnews.com/wp-content/uploads/2012/08/20110126153814-1-150x150.jpg)
Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device.
Read more
Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device.
Read more